FTXH
·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
19.82MUSD
Fund Flows (1Y)
1.26MUSD
Dividend Yield
1.40%
Discount/Premium to NAV
-0.07%
Shares Outstanding
600.00K
Expense Ratio
0.60%
About First Trust Nasdaq Pharmaceuticals ETF
Issuer
First Trust Advisors L.P.
Brand
First Trust
Inception Date
Sep 20, 2016
Structure
Open-Ended Fund
Index Tracked
Nasdaq US Smart Pharmaceuticals Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
First Trust Advisors LP
Distributor
First Trust Portfolios LP
FTXH holds a concentrated basket of 30 highly liquid pharmaceutical stocks weighted according to various factors. While many funds perform a basic liquidity screen as part of their index construction and rebalancing, FTXH goes beyond the basic screen and uses liquidity for selection. The 30 most liquid pharmaceutical stocks in the US are chosen for inclusion in the index as determined by 3-month average daily traded volume. The selected constituents are then ranked and weighted on three different factors: 1) strong growth, as exhibited by 3-, 6-, 9-, and 12-month average price returns, 2) attractive value, evaluated by cash-flow-to-price, and 3) low volatility, based on historical price fluctuations. Single security weights are capped at 8%. The index is rebalanced quarterly and reconstituted annually.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharmaceuticals
Strategy
Multi-factor
Geography
U.S.
Weighting Scheme
Multi-Factor
Selection Criteria
Liquidity
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +3.92% | +16.53% | +21.29% | +23.84% | +19.84% | +28.77% |
NAV Total Return | +3.13% | +13.96% | +20.96% | +18.73% | +20.90% | +39.47% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
99.37%
0.63%
Category
Ratio
North America
99.37%
Europe
0.63%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Blend
Provides exposure to companies of various sizes that exhibit both growth and value characteristics. This category offers a diversified portfolio with a mix of market caps.
Top 10 Holdings
Symbol
Ratio
MRK
Merck
7.47%
JNJ
Johnson & Johnson
7.34%
BMY
Bristol-Myers Squibb
7.06%
ABBV
Abbvie
6.61%
PFE
Pfizer
6.32%
LLY
Eli Lilly
4.51%
CAH
Cardinal Health
4.18%
REGN
Regeneron
4.03%
BIIB
Biogen
3.94%
VRTX
Vertex Pharmaceuticals
3.57%
Top 10 Weight 55.03%
51 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-12 | 2025-12-12 | 2025-12-31 | 0.129 |
| 2025-09-25 | 2025-09-25 | 2025-09-30 | 0.145 |
| 2025-06-26 | 2025-06-26 | 2025-06-30 | 0.089 |
| 2025-03-27 | 2025-03-27 | 2025-03-31 | 0.099 |
| 2024-12-13 | 2024-12-13 | 2024-12-31 | 0.130 |
| 2024-09-26 | 2024-09-26 | 2024-09-30 | 0.122 |
| 2024-06-27 | 2024-06-27 | 2024-06-28 | 0.128 |
Show more
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
